Choosing Antibiotics Based on Local Resistance: A Focus on Outpatient Management

Registration


There isn't a cost to participate in this online course. The estimated time to complete this course is 60 minutes. 

You must login or create an account before enrolling in this educational activity. 

Once you register for the course, you will have 30 days from the date of enrollment to complete the course. The exact date that your access expires will be indicated within the Course Summary box on this webpage.
 

Target Audience

All healthcare professionals.

Educational Need

Antibiograms are essential tools for assessing antibiotic resistance patterns. While these tools are common in hospitals, they are rarely shared with the community. Many treatment guidelines for diseases treated on an outpatient basis (including community-acquired pneumonia, sinusitis, urinary tract infections, and diverticulitis) refer to local resistance patterns for antibiotic selection; however, if antibiograms are not shared beyond the hospital walls, outpatient prescribers will be unable to select empiric antimicrobials without considerable uncertainty.  

Prior publications have documented the process of developing cumulative regional antibiograms, but have not investigated the impact these tools might have. Education on local resistance may prevent unnecessarily broad therapies or selection of ineffective agents that place patients at risk for adverse events. 

Learning Objectives

  • Explain how to interpret an antibiogram and its role in empiric antibiotic selection.
  • Recall current outpatient treatment recommendations for urinary tract infections, community-acquired pneumonia, sinusitis, and diverticulitis.
  • Apply local resistance patterns to a patient case and select appropriate empiric pharmacotherapy.

Terms of Use and Privacy Policy

Recording date: January 19, 2021
Date of original release: January 22, 2021
Most recent review/update: January 22, 2021
Termination date: January 21, 2024

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credits™
  • 1.00 AOA Category 2­B
  • 1.00 CE Contact Hour(s)
  • 1.00 IBON
Course opens: 
01/22/2021
Course expires: 
01/21/2024
Cost:
$0.00

Amanda Bushman, PharmD, BCPS-AQ ID, BCIDP
Infectious Disease Pharmacist, UnityPoint Health - Des Moines

Andrew Miesner, PharmD, BCPS
Associate Professor of Pharmacy Practice, Drake University College of Pharmacy & Health Sciences
Clinical Pharmacist, Broadlawns Medical Center

Benjamin Williamson, BS-Health Sciences
MPH Candidate, Des Moines University

 

Accreditation Statements

  • MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and Drake University. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in the activity. 
  • DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 1.0 AOA Category 2-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
  • Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This activity has been reviewed and approved for 1.0 continuing education contact hour(s). No partial credit awarded.
  • Other Health Professionals: This enduring materials activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.

Educational Grants

No ineligible company provided financial support for this continuing education activity. 

DISCLOSURE

The planning committee member(s) and speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. 

Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.

  • Amanda Bushman, PharmD, BCPS-AQ ID, BCIDP, speaker
  • Benjamin Williamson, BS-Health Sciences, speaker

Relevant to the content of this educational activity, the following individual(s) have a conflict(s) with ineligible companies to disclose. All financial relationships have been mitigated by the accredited provider.

  • Andrew Miesner, PharmD, BCPS, activity director and speaker, does not have a conflict with a commercial interest company, but does intend to discuss off-label uses of commercial products.

Disclaimer

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.

Available Credit

  • 1.00 AMA PRA Category 1 Credits™
  • 1.00 AOA Category 2­B
  • 1.00 CE Contact Hour(s)
  • 1.00 IBON

Price

Cost:
$0.00
Please login or Create an Account to take this course.